104 related articles for article (PubMed ID: 17038906)
1. HLA-identical sibling compared with 8/8 matched and mismatched unrelated donor bone marrow transplant for chronic phase chronic myeloid leukemia.
Arora M; Weisdorf DJ; Spellman SR; Haagenson MD; Klein JP; Hurley CK; Selby GB; Antin JH; Kernan NA; Kollman C; Nademanee A; McGlave P; Horowitz MM; Petersdorf EW
J Clin Oncol; 2009 Apr; 27(10):1644-52. PubMed ID: 19224849
[TBL] [Abstract][Full Text] [Related]
2. The CD34
Remberger M; Grønvold B; Ali M; Mattsson J; Egeland T; Lundin KU; Myhre A; Abrahamsen I; Heldal D; Dybedal I; Tjønnfjord GE; Gedde-Dahl T; Fløisand Y
Clin Hematol Int; 2020 Jun; 2(2):74-81. PubMed ID: 34595446
[TBL] [Abstract][Full Text] [Related]
3. Association between single nucleotide polymorphisms within HLA region and disease relapse for patients with hematopoietic stem cell transplantation.
Chen DP; Chang SW; Wang PN; Hus FP; Tseng CP
Sci Rep; 2019 Sep; 9(1):13731. PubMed ID: 31551439
[TBL] [Abstract][Full Text] [Related]
4. Single nucleotide polymorphisms within HLA region are associated with disease relapse for patients with unrelated cord blood transplantation.
Chen DP; Chang SW; Jaing TH; Wang WT; Hus FP; Tseng CP
PeerJ; 2018; 6():e5228. PubMed ID: 30083439
[TBL] [Abstract][Full Text] [Related]
5. Stem cell transplantation during cancer.
Zhang XY; Zhang PY
Oncol Lett; 2016 Dec; 12(6):4297-4300. PubMed ID: 28105145
[TBL] [Abstract][Full Text] [Related]
6. A prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantation.
Törlén J; Ringdén O; Garming-Legert K; Ljungman P; Winiarski J; Remes K; Itälä-Remes M; Remberger M; Mattsson J
Haematologica; 2016 Nov; 101(11):1417-1425. PubMed ID: 27662016
[TBL] [Abstract][Full Text] [Related]
7. Saudi SCD patients' symptoms and quality of life relative to the number of ED visits.
Ahmed AE; Alaskar AS; McClish DK; Ali YZ; Aldughither MH; Al-Suliman AM; Malhan HM
BMC Emerg Med; 2016 Aug; 16(1):30. PubMed ID: 27543088
[TBL] [Abstract][Full Text] [Related]
8. Reduced-intensity conditioning by fludarabine/busulfan without additional irradiation or T-cell depletion leads to low non-relapse mortality in unrelated bone marrow transplantation.
Nakane T; Nakamae H; Koh H; Nakamae M; Hayashi Y; Nishimoto M; Yoshimura T; Inoue E; Inoue A; Aimoto R; Aimoto M; Terada Y; Koh KR; Yamane T; Hino M
Int J Hematol; 2011 Apr; 93(4):509-516. PubMed ID: 21394567
[TBL] [Abstract][Full Text] [Related]
9. C-reactive protein levels before reduced-intensity conditioning predict outcome after allogeneic stem cell transplantation.
Remberger M; Mattsson J
Int J Hematol; 2010 Jul; 92(1):161-7. PubMed ID: 20577834
[TBL] [Abstract][Full Text] [Related]
10. Hyperferritinemia is associated with low incidence of graft versus host disease, high relapse rate, and impaired survival in patients with blood disorders receiving allogeneic hematopoietic stem cell grafts.
Wahlin A; Lorenz F; Fredriksson M; Remberger M; Wahlin BE; Hägglund H
Med Oncol; 2011 Jun; 28(2):552-8. PubMed ID: 20393815
[TBL] [Abstract][Full Text] [Related]
11. Stable mixed donor-donor chimerism after double cord blood transplantation.
Berglund S; Okas M; Gertow J; Uhlin M; Mattsson J
Int J Hematol; 2009 Nov; 90(4):526-531. PubMed ID: 19697099
[TBL] [Abstract][Full Text] [Related]
12. Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease.
Brunstein CG; Barker JN; Weisdorf DJ; DeFor TE; Miller JS; Blazar BR; McGlave PB; Wagner JE
Blood; 2007 Oct; 110(8):3064-70. PubMed ID: 17569820
[TBL] [Abstract][Full Text] [Related]
13. Reduced-intensity conditioning for allogeneic stem cell transplantation in patients with chronic myeloid leukemia is associated with better overall survival but inferior disease-free survival when compared with myeloablative conditioning - a retrospective study of the Czech National Hematopoietic Stem Cell Transplantation Registry.
Faber E; Koza V; Vitek A; Mayer J; Sedlacek P; Zak P; Zapletalova J; Benesova K; Krejcova H; Steinerova K; Maresova I; Cetkovsky P;
Neoplasma; 2007; 54(5):443-6. PubMed ID: 17688375
[TBL] [Abstract][Full Text] [Related]
14. Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors.
Ayuk F; Diyachenko G; Zabelina T; Panse J; Wolschke C; Eiermann T; Binder T; Fehse B; Erttmann R; Kabisch H; Bacher U; Kröger N; Zander AR
Exp Hematol; 2008 Aug; 36(8):1047-54. PubMed ID: 18456390
[TBL] [Abstract][Full Text] [Related]
15. Nonmyeloablative allogeneic stem cell transplantation (NST) after truly nonmyeloablative and reduced intensity conditioning regimens.
Banna GL; Aversa S; Sileni VC; Favaretto A; Ghiotto C; Monfardini S
Crit Rev Oncol Hematol; 2004 Sep; 51(3):171-89. PubMed ID: 15331077
[TBL] [Abstract][Full Text] [Related]
16. Tacrolimus instead of cyclosporine used for prophylaxis against graft-versus-host disease improves outcome after hematopoietic stem cell transplantation from unrelated donors, but not from HLA-identical sibling donors: a nationwide survey conducted in Japan.
Yanada M; Emi N; Naoe T; Sakamaki H; Takahashi S; Hirabayashi N; Hiraoka A; Kanda Y; Tanosaki R; Okamoto S; Iwato K; Atsuta Y; Hamajima N; Tanimoto M; Kato S
Bone Marrow Transplant; 2004 Aug; 34(4):331-7. PubMed ID: 15220958
[TBL] [Abstract][Full Text] [Related]
17. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
18. Unrelated versus related allogeneic stem cell transplantation after reduced intensity conditioning.
Uzunel M; Remberger M; Sairafi D; Hassan Z; Mattsson J; Omazic B; Barkholt L; Ringdén O
Transplantation; 2006 Oct; 82(7):913-9. PubMed ID: 17038906
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
